Clinical Trials
2 trialsNCT02546661 2025-12-29
BISCAY
AstraZeneca
Phase 1 Active not recruiting
NCT06916494 2025-04-10
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
First Affiliated Hospital of Chongqing Medical University
Phase 1 Recruiting